FIELD: chemistry.
SUBSTANCE: invention relates to novel crystalline form of bimatoprost ((Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenyl-pent-1-enyl]-cyclopentyl]-N-ethyl-hept-5-eneamide), method for thereof obtaining, pharmaceutical composition, containing it, and method for treating ocular hypertension and glaucoma.
EFFECT: novel crystalline form of bimatoprost, possessing higher stability.
8 cl, 7 dwg, 6 tbl
Authors
Dates
2016-03-20—Published
2010-11-19—Filed